What I’ll Be Watching for in the Amgen Oral Arguments
IP Watchdog
MARCH 26, 2023
Sanofi, a case with the parties and 27 Amici, including the United States, weighing in on whether and how the Court should address the enablement requirement of Section 112 in the context of genus claims, and in particular, genus claims to antibodies in the pharmaceutical sciences.
78 
Let's personalize your content